We talk about LABS Quarterly and what it means for other extractors, followed by: HEXO, Sundial, FAF, HITI and ISH quarterlies. Also discuss Zena's zombie raise and the potential for other zombie raises, Acerage's $15MM 60% annual interest loan. Continue with Extractors: <ul> <li style="font-weight: 400;">Will RTI continue to pay for all their expenses in shares.</li> <li style="font-weight: 400;">Will CANN blow off the fact that Cronos vapes are not selling as anticipated.</li> </ul>

We talk about LABS Quarterly and what it means for other extractors, followed by: HEXO, Sundial, FAF, HITI and ISH quarterlies. Also discuss Zena's zombie raise and the potential for other zombie raises, Acerage's $15MM 60% annual interest loan. Continue with Extractors: Will RTI continue to pay for all their expenses in shares. Will CANN blow off the fact that Cronos vapes are not selling as anticipated.

We talk about LABS Quarterly and what it means for other extractors, followed by: HEXO, Sundial, FAF, HITI and ISH quarterlies. Also discuss Zena's zombie raise and the potential for other zombie raises, Acerage's $15MM 60% annual interest loan. Continue with Extractors: <ul> <li>Will RTI continue to pay for all their expenses in shares.</li> <li>Will CANN blow off the fact that Cronos vapes are not selling as anticipated.</li> </ul>

Share Inside the Ropes Episode 33

Sign up to save your podcasts

Inside the Ropes Episode 33

Inside the Ropes Episode 33